Which Body System Produces Red Blood Cells?

·

Share

The body system responsible for producing red blood cells is the hematopoietic system, centered in your bone marrow. This spongy tissue inside your bones churns out roughly 2 million red blood cells every single second — about 200 billion per day. It’s a staggering output, and it happens quietly in the background every moment you’re alive.

Red blood cells (RBCs) carry oxygen from your lungs to every tissue in your body and shuttle carbon dioxide back for exhalation. Without a functioning hematopoietic system, your organs would starve for oxygen within days. So when someone asks “what body system makes red blood cells?” — the answer is your bone marrow-based blood production system, with critical support from your kidneys, liver, and several hormones that keep the whole operation running smoothly.

How the Hematopoietic System Works

The word hematopoiesis literally means “blood making.” It starts with hematopoietic stem cells (HSCs) — rare, multipotent cells that live in bone marrow and can become any type of blood cell: red blood cells, white blood cells, or platelets.

In adults, the most active marrow sites are the pelvis, sternum (breastbone), vertebrae, and the ends of the femur and humerus. In children, nearly every bone contains active red marrow. By adulthood, much of it converts to yellow (fatty) marrow that doesn’t produce blood cells unless the body faces extreme demand.

Erythropoiesis: Red Blood Cell Production Step by Step

The specific process of making red blood cells is called erythropoiesis. Here’s how it unfolds:

  1. Oxygen sensing: Specialized cells in the kidneys detect low blood oxygen levels (hypoxia).
  2. EPO release: The kidneys release erythropoietin (EPO), a hormone that signals the bone marrow to ramp up RBC production. About 90% of EPO comes from the kidneys; the liver contributes the remaining 10%.
  3. Stem cell differentiation: HSCs in the bone marrow differentiate into erythroid progenitor cells, then proerythroblasts, then through several stages of erythroblasts.
  4. Nucleus ejection: Near the end of maturation, the developing cell ejects its nucleus — which is why mature RBCs lack a nucleus and can’t divide.
  5. Reticulocyte release: Young RBCs called reticulocytes enter the bloodstream. Within 1–2 days, they mature into fully functional red blood cells.
  6. Circulation: Each mature RBC circulates for approximately 120 days before being broken down by the spleen and liver.

The entire journey from stem cell to circulating red blood cell takes about 7 days under normal conditions, though the body can accelerate this during acute blood loss or severe anemia.

Key Organs Involved in RBC Production

Organ Role in RBC Production
Bone marrow Primary production site — where stem cells differentiate into red blood cells
Kidneys Produce ~90% of erythropoietin (EPO), the hormone that triggers RBC production
Liver Produces ~10% of EPO; stores iron and vitamin B12; produces thrombopoietin; site of fetal hematopoiesis
Spleen Filters and removes old/damaged RBCs (average RBC lifespan: 120 days)
Stomach/intestines Absorb iron, folate, and vitamin B12 — essential raw materials for RBC production

What Happens When RBC Production Goes Wrong

Disruptions at any point in this system cause measurable disease. Here are the most common problems I see in clinical practice:

Too Few Red Blood Cells (Anemia)

Anemia — defined as hemoglobin below 13.5 g/dL in men or below 12.0 g/dL in women — affects roughly 1.8 billion people worldwide, making it the most common blood disorder on the planet. Common causes include:

  • Iron deficiency: The single most common cause globally. Without adequate iron, the marrow can’t produce enough hemoglobin.
  • Vitamin B12 or folate deficiency: Leads to megaloblastic anemia, where RBCs are abnormally large and dysfunctional.
  • Chronic kidney disease: Damaged kidneys produce less EPO, so the marrow doesn’t get the signal to make enough RBCs. This is why patients on dialysis often need EPO injections.
  • Bone marrow failure: Conditions like aplastic anemia or myelodysplastic syndromes (MDS) damage the marrow’s ability to produce cells altogether.
  • Chronic inflammation: Diseases like rheumatoid arthritis and cancer trigger “anemia of chronic disease,” where the body sequesters iron away from the marrow.

Too Many Red Blood Cells (Polycythemia)

Polycythemia means an excess of red blood cells, typically with a hemoglobin above 16.5 g/dL in men or 16.0 g/dL in women. This thickens the blood and raises the risk of stroke, heart attack, and blood clots.

  • Polycythemia vera (PV): A bone marrow cancer driven by the JAK2 mutation in over 95% of cases. The marrow overproduces RBCs independent of EPO signals.
  • Secondary polycythemia: Caused by chronically low oxygen (from living at high altitude, smoking, or lung disease), which drives EPO production sky-high.

Normal Red Blood Cell Lab Values

Lab Test Normal Range (Men) Normal Range (Women)
Hemoglobin 13.5–17.5 g/dL 12.0–16.0 g/dL
Hematocrit 38.3–48.6% 35.5–44.9%
RBC count 4.7–6.1 million/µL 4.2–5.4 million/µL
Reticulocyte count 0.5–2.5% of total RBCs
EPO level 4–24 mIU/mL

When to See a Doctor

If you’re experiencing persistent fatigue, pale skin, shortness of breath with minimal exertion, dizziness, or unusually rapid heartbeat, ask your doctor for a complete blood count (CBC). This simple, inexpensive blood test measures your RBC count, hemoglobin, hematocrit, and several other indices that reveal whether your hematopoietic system is functioning normally.

You should seek more urgent evaluation if you notice blood in your stool (a sign of chronic blood loss), sudden extreme fatigue after an illness, or a ruddy/flushed complexion with headaches and itching after showers — which can signal polycythemia vera.

For patients already diagnosed with chronic kidney disease, regular monitoring of EPO levels and hemoglobin is essential since failing kidneys progressively lose their ability to stimulate RBC production.

Frequently Asked Questions

Does the skeletal system or the circulatory system produce red blood cells?

Technically, the skeletal system houses the bone marrow where RBCs are made, so many textbooks credit the skeletal system. However, hematologists consider it a function of the hematopoietic system — a distinct system that operates within the bones but is functionally separate from structural skeletal functions. On most anatomy exams, “skeletal system” or “hematopoietic system” are both accepted answers.

Where does red blood cell production happen before birth?

During fetal development, RBC production shifts locations. In the first trimester, the yolk sac handles it. By the second trimester, the liver and spleen take over. Bone marrow becomes the primary site during the third trimester and remains so for life.

Can you boost red blood cell production naturally?

Yes — to a point. Ensuring adequate intake of iron (18 mg/day for premenopausal women, 8 mg/day for men), vitamin B12 (2.4 µg/day), folate (400 µg/day), and copper supports healthy erythropoiesis. Exercise and altitude exposure also naturally stimulate EPO release. However, if your marrow or kidneys are diseased, dietary changes alone won’t fix the problem.

Why do athletes sometimes abuse EPO?

Injecting synthetic EPO forces the bone marrow to overproduce red blood cells, dramatically increasing oxygen-carrying capacity. This is the basis of “blood doping.” It’s banned in competitive sports and genuinely dangerous — artificially elevated hematocrit above 50–55% significantly raises the risk of fatal blood clots.

What happens if bone marrow stops working entirely?

Complete bone marrow failure — as seen in severe aplastic anemia — is life-threatening without treatment. Patients become severely anemic, prone to infections (from lack of white blood cells), and at risk of uncontrolled bleeding (from lack of platelets). Treatment options include immunosuppressive therapy or a bone marrow (stem cell) transplant.

Written by
Haematology, Platelet Biology
Contact [email protected] AmandaUnsworth1 Website Manchester Metropolitan University June 26, 2020 Repurposing anti-cancer drugs: Could Pim kinase inhibitors be the new aspirin? My scientific interests are in understanding the signalling molecules and pathways that regulate platelet function, thrombosis and haemostasis. My research aims to understand the role platelets play in pathological conditions which is essential for the identification of drug targets,…
View Full Profile →
Web Admin Avatar